Neogenomics (NEO) Cash from Investing Activities Growth (1y) (2011 - 2026)
Neogenomics (NEO) Cash from Investing Activities Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 156.94% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -3,832.95% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -165.43% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 32.46% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -10.12% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 24.18% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -148.98% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 95.92% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | -289.16% |
| 10 | Neogenomics | 2.42 Bn | 2.28 Bn | 91.88 Mn | 10.68% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.68% |
| Mar 31, 2026 | -240.45% |
| Dec 31, 2025 | -15.33% |
| Sep 30, 2025 | 92.12% |
| Jun 30, 2025 | -227.36% |
| Mar 31, 2025 | -75.49% |
| Dec 31, 2024 | -131.79% |
| Sep 30, 2024 | -116.89% |
| Jun 30, 2024 | -51.08% |
| Mar 31, 2024 | -38.82% |
| Dec 31, 2023 | 1,717.59% |
| Sep 30, 2023 | 595.97% |
| Jun 30, 2023 | 338.27% |
| Mar 31, 2023 | 97.00% |
| Dec 31, 2022 | 88.91% |
| Sep 30, 2022 | 71.41% |
| Jun 30, 2022 | 98.62% |
| Mar 31, 2022 | 107.79% |
| Dec 31, 2021 | 66.79% |
| Sep 30, 2021 | 79.23% |